🇺🇸 FDA
Patent

US 7709482

Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

granted A61KA61K31/502A61P

Quick answer

US patent 7709482 (Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors) held by Rigel Pharmaceuticals, Inc. expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
62
CPC classes
A61K, A61K31/502, A61P, A61P1/04, A61P11/00